Roundtable Discussion: Discussing the Promises & Challenges of Elevating Neurodegenerative Therapeutics with a Combination Approach
Time: 2:00 pm
day: Conference Day One - Track Three
Details:
More practical and highly interactive breakout roundtables where attendees can crowd-source solutions and share opinions around pre-assigned topic areas.
Are there opportunities to enhance therapies in phase I/II by combining with another treatment to improve them?
What regulatory hurdles might arise when demonstrating the additional risks or benefits of a combination therapy?
How can we avoid risks of drug-drug interactions and decipher the optimal timing of the two therapies?
Moderator Feedback & Audience Debate
Moderators will be assigned to each roundtable to facilitate discussion and collate the findings. Following the roundtable discussions, they will present back to the entire delegation and open wider audience debate
